Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Pfizer Inc (Symbol: PFE). So this week we highlight one interesting put contract, and one interesting call contract, from …
Tara Clarke: Pfizer Inc. (NYSE:PFE) will soon feel the pressure from the wave of lawsuits being filed claiming that Pfizer’s blockbuster drug Lipitor – the world’s best-selling drug of all time – causes type-2 diabetes in women. With a market ...
Investors sentiment decreased to 1.13 in 2016 Q4. Its down 0.05, from 1.18 in 2016Q3. It is negative, as 60 investors …
Woodley Farra Manion Portfolio Management Inc. now owns 106,653 shares of the biopharmaceutical company's stock worth $3,612,000 after buying an additional 284 shares in the last quarter. (NYSE:PFE). Icon Advisers holds 385,200 …
Freestone Capital Holdings Llc acquired 10,639 shares as Pfizer Inc (PFE)'s stock declined 3.45%. The California-based Partnervest Advisory Ltd Liability Company has invested 0.2% in Boeing Co (NYSE:BA). Monroe State Bank And Tru …
Linked here is a detailed quantitative analysis of Pfizer Inc. (PFE). Below are some highlights from the above linked analysis: Company Description: Pfizer Inc. ranks as one of the world's largest pharmaceutical companies, offering a …
Here's a selection of opinions from around the net: From the Wyeth "protest letter" being circulated on Cafe Pharma: ...
The stock rose 0.28% or $0.09 reaching $31.84. Pfizer Inc. (NYSE:PFE)'s stock has performed at -2.25%. It has underperformed by 0.72% the S&P500. LANKLER DOUGLAS M sold $693,200 worth of Pfizer Inc. (NYSE:WSM) is a …
Pfizer Inc. (NYSE:PFE)‘s stock had its “buy” rating restated by stock analysts at Sanford C. Bernstein in a report issued on Monday, April 24th. They currently have a $35.00 price objective on the biopharmaceutical company’s stock. …